# Eddie Eltoukhy

> Eddie Eltoukhy is a seed investor at Pear VC backing Health Care and Biotechnology. See 4 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Pear VC](https://shizune.co/investors/profile/pejman-mar-ventures)
- Location: San Francisco Bay Area, United States
- Total investments: 4
- Last investment: Jun 2026
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/eeltoukhy
- X (Twitter): https://twitter.com/arasha
- Website: https://x.com/arasha

Eddie Eltoukhy is a Partner at Pear VC. He previously worked as the Head of Corporate Development at Senti Biosciences and Business Development MBA Intern at Roche. Eddie attended Stanford University Graduate School of Business, Massachusetts Institute of Technology, and Stanford University.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 2 | 50% |
| Biotechnology | 2 | 50% |
| Medical | 1 | 25% |
| Software | 1 | 25% |
| Wellness | 1 | 25% |

8 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 3 | 75% |
| Pre-Seed | 1 | 25% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Portal | Portal is a cell engineering platform firm that enables next generation cell engineering and cell analytics in research and clinical settings. | $9M | Seed | Jun 18, 2026 |  |
| Greatly Health | Greatly Health provides virtual integrative oncology programs for people living with and beyond cancer. The company offers access to integrative medicine approaches that are designed to complement conventional cancer care. Its services focus on areas such as exercise, nutrition, and mind-body practices delivered through an online platform. GreatlyHealth connects members with structured, evidence-informed programs that aim to help manage treatment side effects and support overall well-being. The platform serves patients, survivors, and caregivers seeking integrative support alongside their oncology care. Greatly Health does not itself deliver medical services and encourages users to maintain care with their existing clinical providers. | $4M | Seed | Apr 30, 2026 |  |
| Portal | Portal is a cell engineering platform firm that enables next generation cell engineering and cell analytics in research and clinical settings. | $5M | Pre-Seed | Mar 19, 2024 |  |
| Infinimmune | Infinimmune operates as a biotechnology company. Infinimmune reinvents antibody discovery with an end-to-end platform to deliver antibody drugs derived directly from the human immune system. | $12M | Seed | Dec 06, 2022 |  |

4 of 4 investments shown.

## Co-investors
- [IKJ Capital](https://shizune.co/investors/profile/ikj-capital) — VC Fund, 2 deals together
- [Playground Global](https://shizune.co/investors/profile/playground-global) — VC Fund, 2 deals together
- [10X Capital](https://shizune.co/investors/profile/10x-capital) — VC Fund, 1 deal together
- [Axial VC](https://shizune.co/investors/profile/axial-vc) — VC Fund, 1 deal together
- [BBQ Capital](https://shizune.co/investors/profile/bbq-capital) — VC Fund, 1 deal together
- [Broocknell Ventures](https://shizune.co/investors/profile/broocknell-ventures) — VC Fund, 1 deal together

## About Pear VC

VC Fund · Palo Alto, United States

Pear is an early-stage venture fund founded by Pejman Nozad and Mar Hershenson. Their co-founding managers have historically seeded very early stage tech start-ups such as Doordash, Guardant Health, Gusto, Viz.ai, Dropbox, Lending Club, Vanta, Zoosk, Addepar, Path and many others.Their motto is simple: they invest in exceptional founders who arebuilding amazing companies. They utilize every resource they have to assist their founders and entrepreneurs shape the future.

5 contacts available at Pear VC.

| Name | Title | Profile |
| --- | --- | --- |
| Addison Leong | Director of Engineering | https://shizune.co/investors/profile/addison-leong |
| Ajay Kamat | Partner | https://shizune.co/investors/profile/ajay-kamat |
| Arash Afrakhteh | Partner | https://shizune.co/investors/profile/arash-afrakhteh |
| Arpan Shah | Visiting Partner | https://shizune.co/investors/profile/arpan-shah-4 |
| Eddie Eltoukhy | Partner | https://shizune.co/investors/profile/eddie-eltoukhy-0d42 |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Eddie Eltoukhy invest in?

Eddie Eltoukhy invests primarily in Health Care, Biotechnology and Medical startups, most often at Seed and Pre-Seed stage. Most of the 4 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Eddie Eltoukhy last invest?

The most recent investment recorded for Eddie Eltoukhy closed in Jun 2026. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co